80 likes | 206 Views
PPPs and innovation. Opportunities and challenges within a European public-public partnership. Goals. Development of new drugs, vaccines and diagnostics HIV, TB and Malaria Capacity building in Africa for research. Art 185. Public-public Co-funding MS and EC Current programme :
E N D
PPPs and innovation Opportunities and challenges within a European public-public partnership
Goals • Development of new drugs, vaccines and diagnostics • HIV, TB and Malaria • Capacity building in Africafor research M. I. Esveld, Ministerie van VWS – 24 september 2013
Art 185 • Public-public • Co-funding MS and EC • Currentprogramme: • 2003-2010…2013 • 200 mln+200 mln • 14 Members • EEIG • Secretariat in NL M. I. Esveld, Ministerie van VWS – 24 september 2014
Scope Phase II/III Networks of Excellence Training onethics, (financial) management Clinical trials registry Governance General Assembly Steering Committee ExecutiveSecretriat StrategicAdvisoryCommittee M. I. Esveld, Ministerie van VWS – 24 september 2013
Why a PPP? Marketfailure Limitedcapacity in Sub-saharaAfrica • Youcannotperformclinical tests in Europe Economy of scale Whatabout the private sector? Under EDCTP1: high ambitions, littleresults • Training providedby EFPIA members • Product development partnerships seen as competitors Under EDCTP2?? M. I. Esveld, Ministerie van VWS – 24 september 2013
Issues Membership Participation of new MS and African partners Governance Participation of African partners Participation of non-KP7 members Participation of private sector Balance of power M. I. Esveld, Ministerie van VWS – 24 september 2013
Issues - continued Scope OtherNeglectedTropicalDiseases Otherphases (I/IV) and Health Systems Otherregions (Asia, LatinAmerica) Funding Total budget Cash versus ‘in kind’ Common pot orearmarking Contribution ‘poorcountries’ M. I. Esveld, Ministerie van VWS – 24 september 2013